Characteristics of Clinical Trial Participants with Duchenne Muscular Dystrophy: Data from the Muscular Dystrophy Surveillance, Tracking, and Research Network (MD STAR<i>net</i>)
Background: Therapeutic trials are critical to improving outcomes for individuals diagnosed with Duchenne muscular dystrophy (DMD). Understanding predictors of clinical trial participation could maximize enrollment. Methods: Data from six sites (Colorado, Iowa, Piedmont region North Carolina, South...
Saved in:
Main Authors: | Katherine D. Mathews (Author), Kristin M. Conway (Author), Amber M. Gedlinske (Author), Nicholas Johnson (Author), Natalie Street (Author), Russell J. Butterfield (Author), Man Hung (Author), Emma Ciafaloni (Author), Paul A. Romitti (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Duchenne Muscular Dystrophy
by: J Gordon Millichap
Published: (1989) -
Theragnosis for Duchenne Muscular Dystrophy
by: Leonela Luce, et al.
Published: (2021) -
Muscular Fatigue in Duchenne Dystrophy
by: J Gordon Millichap
Published: (1995) -
Glucocorticoids for Duchenne Muscular Dystrophy
by: J Gordon Millichap
Published: (2013) -
Tracking progress: an update on animal models for Duchenne muscular dystrophy
by: Dominic J. Wells
Published: (2018)